PleuritisNCT01011881
Procalcitonin in Pleural Pleuritis
An observational study of Pleuritis and Pleural Empyema, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.
Trial summary
The purpose of this study is to determine pleural level of procalcitonin in differents situations of pleuritis. Read more about this study
- Who is it for?
- Ages 18 to 99 years
- Conditions the study is for
- Pleuritis, Pleural Empyema
- What is being tested?
- pleural level of procalcitonin
- How many people
- 34 participants
- Where
- 1 siteFrance
- Study dates
- Oct 2009to Feb 2011
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: patients with pleuritis
Who may be able to join
- Pleuritis
- Hospitalisation
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Evaluation de la Mesure du Taux de la Procalcitonine Dans Les Liquides Pleuraux
The purpose of this study is to determine pleural level of procalcitonin in differents situations of pleuritis.
Read the detailed description
Determine pleural level of procalcitonin in pleuritis. Two periods First period evaluation in vitro study/ Determine adequat technique included type of samples tubes for adequat analysis.
Second periods : Patient with pleuritis . Empyema or not
- Conditions
- Pleuritis, Pleural Empyema
- Being tested
- pleural level of procalcitonin
- Keywords
- pleuritis, empyema, procalcitonin
- Medical subject headings
- Pleurisy, Empyema, Pleural, Empyema
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
pleural level of procalcitoninOther
no intervention
| Study group | Role | What they receive |
|---|---|---|
| patients with pleuritis | Not described Receives: Other: pleural level of procalcitonin |
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Nov 2009 (estimated)
- Study startOct 2009
- Primary completionFeb 2011
- Study completionFeb 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PleuritisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 34 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire, Amiens
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01011881
- Sponsor's protocol ID
- PI09-DR-DOUADI
- Status last verified
- Jun 2016
- First submitted
- 10 Nov 2009
- Last updated
- 9 Jun 2016
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Jun 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation de la Mesure du Taux de la Procalcitonine Dans Les Liquides Pleuraux
- ClinicalTrials.gov ID
- NCT01011881
- Acronym / sponsor ID
- PI09-DR-DOUADI
- Conditions
- Pleuritis, Pleural Empyema
- Keywords
- pleuritis, empyema, procalcitonin
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 34 participants (actual)
- Lead sponsor
- Centre Hospitalier Universitaire, AmiensUniversity, hospital or other
- Study start
- Oct 2009
- Primary completion
- Feb 2011 (actual)
- Study completion
- Feb 2011 (actual)
- First posted
- 11 Nov 2009 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine pleural level of procalcitonin in differents situations of pleuritis.
Detailed description
Determine pleural level of procalcitonin in pleuritis. Two periods First period evaluation in vitro study/ Determine adequat technique included type of samples tubes for adequat analysis.
Second periods : Patient with pleuritis . Empyema or not
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| patients with pleuritis | – | Other: pleural level of procalcitonin |
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- patients with pleuritis
Key inclusion criteria (2 listed)
- Pleuritis
- Hospitalisation
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| pleural level of procalcitoninno intervention | Other | patients with pleuritis |
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jun 2016.
Related trials for Pleuritis
RecruitingObservational study
Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA in Hong Kong
Tuberculosis, Pleural, Pleural Biopsy
RecruitingEarly Phase 1
Study of the Feasibility and Efficacy of PrednisonE for Non-specifiC pleuriTis
Pleuritis, Non-specific
Not yet recruitingObservational study
Pleural Effusion Types in Chronic Kidney Disease
Pleural Effusion, Chronic Kidney Disease
RecruitingObservational study
Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA
Tuberculosis, Pleural
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pleuritis and Pleural Empyema, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2016.